Acknowledgements This work was co-funded by the German Research Foundation (DFG), the State of North Rhine-Westphalia (NRW), the European Union (European Regional Development Fund: Investing In Your Future) (EFRE-800400), DDHD (Drug Discovery Hub Dortmund), the German Federal Ministry of Education and Research (InCa, 01ZX2201B), the Mercator Research Center Ruhr (MERCUR, IGNITE (Ex-2021-0033)), the German Cancer Aid ((Deutsche Krebshilfe), Targeting Transcriptional Addiction in Cancer (TACTIC (70115201) is part of the preclinical cancer drug development network (preCDD))), the Netzwerke 2021 program, an initiative of the Ministry of Culture and Science of the State of North Rhine-Westphalia (CANcer TARgeting, NW21-062 C) and, supported by the European Synchrotron Radiation Facility (ESRF, Grenoble, France, proposal MX-2580, beamline ID30B
GLP-1 is a hormone naturally produced in the small intestine
Start (Weeks 12): 20 mcg daily to assess tolerance, particularly regarding blood glucose effects [6]
Instead, she recommends eating in a way that maximizes the benefits of different food groups
3 ), drugs that can bypass the leptin transporter are being explored
The Problem Not All Weight Loss is Good Weight Loss GLP-1 medications like Ozempic, Wegovy, and Mounjaro are transforming the way people lose weight